Haemopoietic cell transplantation in patients living with HIV

Research output: Contribution to journalReview articlepeer-review

Abstract

Haemopoietic cell transplantation is established as a standard treatment approach for people living with HIV who have haematological malignancies with poor prognosis. Studies with autologous and allogeneic haemopoietic cell transplantation suggest that HIV status does not adversely affect outcomes, provided that there is adequate infection prophylaxis. Attention to possible drug–drug interactions is important. Allogeneic haemopoietic cell transplantation substantially reduces the long-term HIV reservoir when complete donor chimerism is established. When transplants from CCR5Δ32 homozygous donors are used, HIV cure is possible.

Original languageEnglish (US)
Pages (from-to)e652-e660
JournalThe Lancet HIV
Volume7
Issue number9
DOIs
StatePublished - Sep 2020

ASJC Scopus subject areas

  • Epidemiology
  • Immunology
  • Infectious Diseases
  • Virology

Fingerprint Dive into the research topics of 'Haemopoietic cell transplantation in patients living with HIV'. Together they form a unique fingerprint.

Cite this